Source: Virtual Congress 2021 – Lung disease burden and management



Rating:

Share or cite this content

Citations should be made in the following way:
A. Jordan (Copenhagen N, Denmark), P. Sivapalan (Copenhagen N, Denmark), J. Ëklof (Copenhagen N, Denmark), J. Vestergaard (Copenhagen N, Denmark), H. Meteran (Copenhagen N, Denmark), M. Saeed (Copenhagen N, Denmark), T. Biering-Sørensen (Copenhagen N, Denmark), A. Løkke (Copenhagen N, Denmark), F. Knop (Copenhagen N, Denmark), N. Seersholm (Copenhagen N, Denmark), J. Jensen (Copenhagen N, Denmark). Use of inhaled corticosteroids and the risk of depressive symptoms in patients with chronic obstructive pulmonary disease. 2151

Member's Comments

No comment yet.

Related content which might interest you: Frequency of depressive syndrome in patients with bronchial asthma and chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions Year: 2021 Inhaled corticosteroids and the risk of a first exacerbation in COPD patients Source: Eur Respir J 2004; 23: 692-697 Year: 2004 Dyspnoea, depression and anxiety in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 55s Year: 2001 Early versus late pulmonary rehabilitation on anxiety and depression in chronic obstructive pulmonary disease patients with acute exacerbations Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation Year: 2012 The efficacy and treatment length of oral corticosteroids in patient with acute exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 295s Year: 2005 Evaluation of bronchodilator responses in chronic obstructive pulmonary disease patients Source: Eur Respir J 2002; 20: Suppl. 38, 247s Year: 2002 Use of metoprolol succinate in patients with cardiovascular diseases associated with asthma or chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 502s Year: 2006 Determinants of depression at exacerbation in chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007 Audit of inhaled corticosteroid prescription in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - COPD: management Year: 2010 Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006 Osteoporosis risk assessment in elderly male patients with COPD who use inhaled corticosteroids Source: Annual Congress 2006 - COPD therapy Year: 2006 Smoking and dyspnea severity in patients with chronic obstructive pulmonary disease Source: International Congress 2017 – Passive smoking and epidemiology Year: 2017 Inhaled corticosteroids and hospitalisation due to exacerbation of COPD Source: Eur Respir J 2003; 22: 286-289 Year: 2003 Prevalence of anxiety and depression in 196 patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - COPD comorbidities I Year: 2012 Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 521s Year: 2004 Assessment of treatment efficiency in patients with chronic obstructive pulmonary disease combined with gastroesophageal reflux disease during treatment with melatonin Source: International Congress 2014 – Clinical presentations Year: 2014 Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 146s Year: 2001 The efficacy of formoterol in patients with chronic obstructive pulmonary disease (COPD) is not influenced by concomitant corticosteroid use Source: Eur Respir J 2001; 18: Suppl. 33, 515s Year: 2001 Assessment of nicotine dependence in healthy people and patients with chronic pulmonary obstructive disease or bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 134s Year: 2002 Effects of inhaled corticosteroids on airway inflammations of different types in patients with chronic obstructive pulmonary disease or asthma in stable phase Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009